Atom Investors LP Caribou Biosciences, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.58 - $6.25 $133,297 - $232,712	37,234 Added 30.17%	160,661 $920,000
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $503,582 - $1 Million	123,427 New	123,427 $589,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $9.74 $75,704 - $144,580	14,844 New	14,844 $81,000
Q1 2022 May 16, 2022	SELL	$8.42 - $15.32 $137,439 - $250,068	-16,323 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.59 - $23.26 $238,152 - $379,672	16,323 New	16,323 $246,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.